American Diabetes Association Pathway to Stop Diabetes 2024

To:	Chairs and Administrators, Departments in the Biological & Physical Sciences; Associate Deans for Research; College/School Research Administrators
From:	Office of the Vice Chancellor for Research & Graduate Education
Date:	April 15, 2024
Subject:	American Diabetes Association Pathway to Stop Diabetes 2024

Deadline

Deadline for Internal Review:

May 13, 2024

Project Description

The Pathway to Stop Diabetes® program intends to attract brilliant scientists approaching the peak of their careers in diabetes research, and to accelerate their research progress by providing the necessary resources and support for conducting transformative science.

This call for nominations will prioritize exceptional investigators across the spectrum of diabetes research, spanning basic science through public health research and implementation science. The ideal applicant will propose innovative research with the ultimate goal of improving the lives of people at risk of diabetes or living with the disease – and the pathway to this impact is clear.

Nominations are welcomed from all areas of diabetes and span prevention, management, and cure of all diabetes types (i.e. type 1, type 2 and gestational), diabetes-related disease states (obesity, prediabetes, and other insulin resistant states) and complications. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics, and physics.

Two funding mechanisms are available:

Accelerator Award
The Pathway to Stop Diabetes® Accelerator award is intended to provide flexible, long-term salary and research support to early career researchers who are proposing innovative and ambitious diabetes-related research programs, and who have distinguished themselves as exceptionally talented and promising research investigators.

Initiator Award
The Pathway to Stop Diabetes® Initiator award is designed to support early career researchers who have distinguished themselves during their research training as exceptionally talented and promising research investigators with a high likelihood of establishing successful, independent research programs and making seminal contributions in diabetes research.

Amount per Award:  Up to $1.625 million Dependent on program
Duration of Award:  5 – 7 Years Dependent on program

Eligibility

Accelerator Award (for early-career diabetes investigators)
Applicants must hold independent faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K or R awards, including an initial NIH R01) but must not have applied for, or received, an NIH R01 renewal or a second R01 award. Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree. Candidate’s must hold a full-time appointment at their sponsoring institution. Rare exceptions to full-time positions may be granted on a case-by-case basis and must be pre-approved by ADA Research Programs staff prior to application submission.

Initiator Award (for researchers in postdoctoral training)
Applicants must currently be in research training positions (i.e. post-doctoral fellowships, research fellowships) and can have no more than seven (7) years of training since their doctoral degree. Initiator award recipients cannot concurrently hold an NIH K99/R00 grant. All other Career Development awards are allowable (unless holding of concurrent awards is prohibited by the other granting agency). Candidate’s must hold a full-time appointment at their sponsoring institution. Rare exceptions to full-time positions may be granted on a case-by-case basis and must be pre-approved by ADA Research Programs staff prior to application submission. Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.

UW-Madison is allowed up to two nominations with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research.

Examples of basic through preclinical research studies (for nomination #1) include:
• Innovative mechanistic studies on fundamental or new aspects of biology
• Novel insights derived from data science using AI/Machine Learning
• Development of new technologies, devices, and/or experimental approaches
• Identification and validation of novel and unique therapeutic targets

Examples of clinical through public health research (for nomination #2) include:
• Clinical experimental medicine studies
• Identification and validation of novel biomarkers
• Health services research
• Behavioral research
• Population epidemiology
• Health economics research
• Patient preference / Quality of Life
• Dissemination and implementation science
• Health Care system-based interventions

To assure continued excellence and diversity among applicants and awardees, the Association welcomes applications from all qualified individuals and strongly encourages applications from persons with diverse backgrounds, including minority groups that are underrepresented in biomedical research.

Nominees are required to devote at least 75% of their total time and effort to research during the funding period. In addition, nominees must devote a specific required percent effort for each of the award types.

Website

The following link contains additional information on the program and specific application instructions:
https://professional.diabetes.org/research-grants/current-funding-opportunities-pathway-stop-diabetes

Internal Competition Application Instructions

Sponsor Deadlines

Applications are due to ADA by July 17, 2024.

Questions?

Contact grants@research.wisc.edu.